Literature DB >> 1961018

Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.

P Jonveaux1, R Berger.   

Abstract

Alterations of the P53 tumor suppressor gene are present in various human malignancies. P53 mutations have recently been detected in 60% of human T-cell leukemia permanent cell lines. To determine the frequency of P53 mutations in primary T-cell acute lymphoblastic leukemia (T-ALL), a powerful method for the detection of structural alterations of DNA was used, namely, single-strand conformation polymorphism analysis of DNA fragments amplified by the polymerase chain reaction. No point mutation in the P53 gene was shown in any of the 30 T-ALL patients tested. Unlike T-cell leukemia permanent cell lines, P53 mutations are uncommon in T-ALL.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961018

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia.

Authors:  David M Langenau; Hui Feng; Stephane Berghmans; John P Kanki; Jeffery L Kutok; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-12       Impact factor: 11.205

2.  P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

Authors:  J Yeargin; J Cheng; A L Yu; R Gjerset; M Bogart; M Haas
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

3.  Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma.

Authors:  K Iyota; K Takeda; F Matsuzuka; T Okabayashi; S Morita; K Kuma; K Hashimoto
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

4.  Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.

Authors:  A Y Matsushima; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

5.  Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.

Authors:  Min Li; Xiang Zhang; Wen-jing Zhou; Yue-hua Chen; Hui Liu; Lin Liu; Chun-mei Yang; Wen-bin Qan
Journal:  Acta Pharmacol Sin       Date:  2013-11-18       Impact factor: 6.150

6.  Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.

Authors:  Y M Zhu; L Foroni; I G McQuaker; M Papaioannou; A Haynes; H H Russell
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.

Authors:  Yinfei Tan; Eleonora Sementino; Jinfei Xu; Jianming Pei; Zemin Liu; Timothy K Ito; Kathy Q Cai; Suraj Peri; Andres J P Klein-Szanto; David L Wiest; Joseph R Testa
Journal:  Oncotarget       Date:  2017-02-28

Review 8.  The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

Authors:  A J Levine; M E Perry; A Chang; A Silver; D Dittmer; M Wu; D Welsh
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.